TITLE:
Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

CONDITION:
HIV Infections

INTERVENTION:
Fat Emulsion 2%

SUMMARY:

      To compare two lipid emulsions in the long-term parenteral alimentation of patients with
      AIDS in relation to: Clinical effectiveness. Effect on immunologic function. Effect on HIV
      load as measured by p24 antigen levels. Effect on relative HIV infectivity.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 60 Years
Criteria:

        Inclusion Criteria

        Concurrent Medication:

        Allowed:

          -  Zidovudine (AZT).

          -  All drugs used for the standard treatment of opportunistic infections.

          -  Other drugs used for the treatment of other AIDS conditions if they have been started
             more than 3 months prior to study entry.

        Patients must have:

          -  Diagnosis of AIDS.

          -  Weight loss of > 10 percent premorbid body weight.

          -  Presenting diagnosis of either opportunistic infection or Kaposi's sarcoma.

          -  Require home total parenteral nutrition (TPN) for a period of approximately 3 months.

          -  Life expectancy = or > 90 days.

        Prior Medication:

        Allowed:

          -  Zidovudine (AZT).

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following conditions or symptoms are excluded:

          -  Life expectancy < 90 days.

          -  Biliary stasis.

          -  History of drug abuse.

        Patients with the following are excluded:

          -  Life expectancy < 90 days.

          -  Biliary stasis.

          -  History of drug abuse.

        Prior Medication:

        Excluded within 3 months of study entry:

          -  Immunomodulators.

          -  Experimental antiviral DT. History of drug abuse.
      
